Liraglutide
- Product NDC
- 70377-095
- 11-digit product format
- 703770095
- Labeler code
- 70377
- Product ID
- 70377-095_15f41bf3-b403-b32c-e64f-2330120c519e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liraglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Biocon Pharma Inc.
- Application
- ANDA217063
- Marketing category
- ANDA
- Marketing start
- 2026-03-27
- Substance
- LIRAGLUTIDE
- Active strength
- 6 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 839I73S42A | LIRAGLUTIDE | 204656-20-2 | LIRAGLUTIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70377-095-52 | 70377009552 | 3 SYRINGE, PLASTIC in 1 CARTON (70377-095-52) / 3 mL in 1 SYRINGE, PLASTIC | 2026-03-27 | No | No | Historical |
| 70377-095-53 | 70377009553 | 5 SYRINGE, PLASTIC in 1 CARTON (70377-095-53) / 3 mL in 1 SYRINGE, PLASTIC | 2026-03-27 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Liraglutide | Biocon Pharma Inc. | Biocon Pharma Limited | Biocon Biologics Limited | 2025-10-16 | HUMAN PRESCRIPTION DRUG LABEL | 8 |